CliffBio
small molecule

CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER

CEPHALOTHIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
Active ingredientCEPHALOTHIN SODIUM
StrengthEQ 40MG BASE/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJanuary 1984
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.